ab33918 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab33918 は 10 報の論文で使用されています。

  • Wang M  et al. miR-302a inhibits human HepG2 and SMMC-7721 cells proliferation and promotes apoptosis by targeting MAP3K2 and PBX3. Sci Rep 9:2032 (2019). PubMed: 30765768
  • Wilkinson EL  et al. Statin regulated ERK5 stimulates tight junction formation and reduces permeability in human cardiac endothelial cells. J Cell Physiol 233:186-200 (2018). WB ; Human . PubMed: 28639275
  • Lu J  et al. MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function. Oncogene 37:3864-3878 (2018). PubMed: 29662197
  • Fulford L  et al. The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5. Sci Signal 9:ra48 (2016). PubMed: 27165781
  • Huang T  et al. MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer. Int J Oncol 49:1437-44 (2016). PubMed: 27498924
  • Mazur PK  et al. SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer. Nature 510:283-7 (2014). WB ; Mouse, Human . PubMed: 24847881
  • Brown RD  et al. MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 304:H269-81 (2013). PubMed: 23125215
  • Jiang L  et al. Overexpression of MEKK2 is associated with colorectal carcinogenesis. Oncol Lett 6:1333-1337 (2013). WB ; Human . PubMed: 24179519
  • Cazares LH  et al. Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Clin Cancer Res 15:5541-51 (2009). IHC-Fr ; Human . PubMed: 19690195
  • Chaveroux C  et al. Identification of a novel amino acid response pathway triggering ATF2 phosphorylation in mammals. Mol Cell Biol 29:6515-26 (2009). PubMed: 19822663

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

登録